RMD - ResMed Secures Significant Victory in Patent Fight Against New York University | Benzinga
SAN DIEGO, Dec. 11, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE:RMD, ASX: RMD)) announced that it has secured a significant victory after the United States Patent Trial and Appeals Board (PTAB) invalidated the claims New York University (NYU) asserted against ResMed, based on seven NYU patents.
In June 2021, NYU filed a complaint for patent infringement against ResMed in the United States District Court, District of Delaware. NYU's complaint alleged that the AutoSetTM and AutoRampTM features of ResMed's AirSenseTM 10 AutoSet flow generators, infringed one or more claims of seven NYU patents.
ResMed filed petitions with the PTAB asserting that all the claims asserted against ResMed were invalid. In rulings issued from December 4 to December 7, 2023, the PTAB judges, agreeing with ...